文献速递免疫规划

美国儿童第四剂DTaP疫苗同步接种的错过机会

Missed opportunities for simultaneous administration of the fourth dose of DTaP among children in the United States.
PubMed 文献 · Vaccine · 2017-05-04

本研究利用2001-2014年美国国家免疫调查数据,描述19-35月龄儿童第四剂DTaP同步接种错过机会的趋势、流行率及风险因素。结果显示错过机会流行率范围为5.7%至9.0%,13个因素下流行率3.3%至22.9%;第一至第三剂DTaP延迟接种者错过第四剂同步接种的流行率显著高于按时接种者(调整流行率比分别为1.7、1.6、3.2,所有P值<0.01)。结论为改善第三剂DTaP按时接种可大幅减少第四剂同步接种的错过机会。

要点

  • 2001-2014年美国19-35月龄儿童第四剂DTaP同步接种错过机会流行率为5.7%至9.0%。
  • 第一至第三剂DTaP延迟接种者错过第四剂同步接种的调整流行率比分别为1.7、1.6、3.2,均P<0.01。
  • 改善第三剂DTaP按时接种可大幅减少第四剂同步接种的错过机会。

核心结论

  • 改善第三剂DTaP按时接种可大幅减少第四剂DTaP同步接种的错过机会。

研究设计与样本

  • 本研究使用2001-2014年美国国家免疫调查数据,分析19-35月龄儿童第四剂DTaP同步接种错过机会的趋势、流行率及风险因素。

主要发现

  • 2001至2014年,美国19-35月龄儿童第四剂DTaP同步接种错过机会的流行率范围为5.7%至9.0%。
  • 在考虑的13个因素中,错过机会的流行率范围为3.3%至22.9%。
  • 第一至第三剂DTaP延迟接种的儿童错过第四剂同步接种的流行率显著高于按时接种儿童,调整流行率比分别为1.7、1.6、3.2,所有P值<0.01。

关键数值与推荐

  • 第四剂DTaP同步接种错过机会定义为:未接种适龄第四剂DTaP,且在同一适龄期内接种了其他推荐且适龄的疫苗。
  • 美国19-35月龄儿童≥4剂DTaP接种覆盖率未达到Healthy People 2020目标90%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Simultaneous administration of all age-appropriate doses of vaccines is an effective strategy for raising vaccination coverage. Vaccination coverage for ≥4 dose of DTaP (diphtheria, tetanus toxoids, and acellular pertussis vaccine) among children 19-35months in the United States has not reached the Healthy People 2020 target of 90%. Risk factors for missed opportunities for simultaneous administration of the fourth dose of DTaP have not been investigated. METHODS: A missed opportunity for simultaneous administration of the fourth dose of DTaP is defined as the failure to administer an age-eligible fourth dose of DTaP, and during the same age-eligible period for the fourth dose of DTaP other recommended and age-appropriate doses of vaccines are given to children. This study used 2001-2014 National Immunization Survey data to describe the trend in missed opportunities for simultaneous administration of the fourth dose of DTaP from 2001 through 2014, assess the prevalence of children who missed opportunities for simultaneous administration of the fourth dose of DTaP by selected factors, and recognize significant risk factors for missed opportunities for simultaneous administration of the fourth dose of DTaP. RESULTS: From 2001 to 2014, the prevalence of missed opportunities for simultaneous administration of the fourth dose of DTaP among children 19-35months in the United States ranged from 5.7% to 9.0%; across 13 factors considered, the prevalence of missed opportunities varied from 3.3% to 22.9%. Children who were late in receiving the first to third dose of DTaP had significantly higher prevalence of missed opportunities for simultaneous administration of the fourth dose of DTaP than children who received these doses on-time, with adjusted prevalence ratios for late vs. on-time of 1.7, 1.6, and 3.2, and all P-value<0.01. CONCLUSIONS: Improving on-time vaccination of the third dose of DTaP could substantially reduce missed opportunities for simultaneous administration of the fourth dose of DTaP.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Zhao Z, Smith PJ, Hill HA, et al. Missed opportunities for simultaneous administration of the fourth dose of DTaP among children in the United States. Vaccine. 2017. PMID: 28479179. doi:10.1016/j.vaccine.2017.04.070

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。